Home›People›Michael Stansky
MS

Michael Stansky

Director at Potrero Medical.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing May 29, 2026·Suggest an edit

About Michael Stansky

Michael Stansky is a director at Potrero Medical.

Michael Stansky reports to the SEC as a director or major shareholder of 2 public companies: TriSalus Life Sciences (TLSI) and MAKO Surgical (MAKO).

Michael Stansky first appears on SEC filings in 2008.

Experience

This experience comes from SEC filings. The years are when the filings name Michael Stansky in the role, so the role may have started earlier or lasted longer.

Potrero Medical, Inc.
Director
2026 · Hayward, CA
Medical monitoring systems help clinicians track critically ill patients' kidney function.
TriSalus Life Sciences, Inc.
Director
2026 · Public company (TLSI)
MAKO Surgical Corp.
Director and 10% owner
2008 · Public company (MAKO)

Key Colleagues at Startups

The people Michael Stansky works with at each company, as listed on that company's latest Form D.

Potrero Medical, Inc. · Form D, May 29, 2026
RR
Ram Reddy
Director
Rich Keenan
Rich Keenan
Sr. Regional Vice President of Sales
DM
David Matlin
Director
Khalid Ghafari
Khalid Ghafari
Chief Financial Officer
Christopher Dewey
Christopher Dewey
Executive Chairman
CH

Sources

  1. SECPotrero Medical, Inc. Form D, filed May 29, 2026
  2. SECForms 3, 4 and 5 filed by Michael Stansky (SEC filer 1424204)